Please login to the form below

Not currently logged in

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Google backs Indian mobile online doctor community

Curofy wins support from the firm's Launchpad Accelerator programme

Digital pharma CurofyA new online mobile network for doctors is among the startups to receive the backing of Google's Launchpad Accelerator programme.

Curofy claims to be India's largest online community of verified doctors, with over 190,000 members from more than 600 cities.

Its flagship app, which is available for both Apple and Android devices, allows them to discuss medical cases and provides access to medical news and jobs. 

Curofy's co-founder Pawan Gupta told BWDisrupt: "Google Accelerator provides a great opportunity for Indian startups to be mentored in best product and engineering practices followed in Silicon Valley. The learning and exposure from the accelerator will prepare Curofy's product for its growth beyond India".

As it does so one of its competitors will likely be MedShr, which was launched last year by a UK doctor as a similarly mobile-first social work.

Curofy, which is based near New Delhi in Gurgaon, joins the third wave of startups in the Google's Launchpad programme, among them a word game app and one for CRM.

The companies are now inline for six months mentorship and a share of $50,000 in equity-free funding.

20th December 2016

From: Healthcare



Featured jobs

Subscribe to our email news alerts


Add my company

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...